Clinical Trial Update: Phase I Study of Intrathecal Topotecan [Phase 1]

View source ↗

Summary

Phase I study evaluating intrathecal topotecan for leukemia, lymphoma, and meningeal neoplasms has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia
• Lymphoma
• Meningeal Neoplasms

Drugs mentioned

• Topotecan (Hycamtin) (Topotecan)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Leukemia, Lymphoma | Phase 1 | Status: COMPLETED